[Retracted] E2F1 Affects the Therapeutic Response to Neoadjuvant Therapy in Breast Cancer

Figure 9

The enriched pathways of four TFs: FOXA1 (a), PGR (b), HOXA9 (c), and E2F1 (d).

(a)

(b)

(c)

(d)